… activity of ionizing radiation as well as the anthracycline topoisomerase II inhibitor, daunorubicin,
alone or in combination with cytarabine, in AML cell … synergize with bortezomib in this …

… the AML cells against cytotoxic agents such as BH3-mimetics, cytarabine and daunorubicin.
We … Next, we investigated the mechanism through which the BMM protects the FLT3-ITD …

… inducing the reversible multidrug resistance phenotype in ALL cells [5]… , including proteasome
inhibitors such as bortezomib and … chemotherapy agents, cytarabine and daunorubicin [3]. …

… squamous cell carcinoma, which can lead to anthracycline resistance … in the emergence
of bortezomib resistance 86 . SMC1A … Anchorage-independent growth is one of the defining …

… While the combination of cytarabine and anthracyclines (7 + 3… ) induces p53-independent
apoptosis upon binding to its cell … Bortezomib inhibits the 26S subunit of proteasome complex …

… transporters MDR1, multidrug resistance associated protein … initial treatment of AML (notably
anthracyclines) can have off-… decreased in vitro by the proteasome inhibitor bortezomib, or …

… . tested the ex-vivo drug activity of cytarabine, idarubicin, and their … sensitivity to different
anthracyclines, and every third of the … , gilteritinib, dasatinib, and bortezomib are not yet included, …

… of the potential therapeutic activity of SHARP1 knockdown using … Cytarabine and Anthracycline
combination is still regarded as a … Interactions between bortezomib and romidepsin and …

… Cytarabine (AraC), a nucleoside drug used in patients with … (also known as multidrug
resistance-associated proteins, MRPs… taxanes, vinca alkaloids, and anthracyclines. The spectrum …

… Bortezomib inhibits the expression and secretion of vascular … a sodium- and pH-independent
transporter that provides vital … Multiple drug resistance (MDR) contributes to the failure of …